Journal of Chemotherapy

Papers
(The H4-Index of Journal of Chemotherapy is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis84
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam63
Innovative sequential therapy in a rare case of refractory Erdheim-Chester disease with bilateral pulmonary involvement35
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer30
Cytofluorimetric study of cerebrospinal fluid at staging of diffuse large B cell lymphoma22
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis21
YAP/TAZ axis was involved in the effects of metformin on breast cancer18
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients15
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer14
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem12
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae11
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database11
0.41918301582336